Glenn Morrison PhD

Prof. Morris is a professor of biochemistry at Keele University. He received a B.A. from Cambridge, a D. Phil. from Sussex and a Beit Memorial Fellowship for postdoctoral research at the Universities of Sussex and Connecticut. He has received research grant support from MRC, SERC, NIH and a number of UK, European and US medical charities, including the British Heart Foundation. He joined with the Neuromuscular Team at Oswestry in 2004 to create the Centre for Inherited Neuromuscular Disease (CIND) and contributed to the design of, and fundraising for, the new TORCH Building, opened in 2007.

At the Institute, Prof. Morris is Research Director for CIND and collaborates closely with Prof. Caroline Sewry, muscle pathologist in the team, and Dr Tracey Willis, the clinical lead. Current research is centred on finding treatments for Duchenne muscular dystrophy, congenital and limb-girdle muscular dystrophies, Emery-Dreifuss muscular dystrophy, inherited cardiomyopathies, myotonic dystrophy and spinal muscular atrophy. His team produce novel monoclonal antibodies as reagents for diagnosis and monitoring of clinical trials of new drugs for these inherited disorders. More recently, they have used proteomic methods (mass spectrometry) to identify new targets for drug development. They also run the international Monoclonal Antibody Resource, funded by the Muscular Dystrophy Association (USA).